Lisata Therapeutics, Inc.
Jeffrey S Farrow (Director) reports LSTA insider transactions
About this filing
Lisata Therapeutics, Inc. (LSTA) filed Form 3 (initial insider holdings) with the SEC on Oct 15, 2026.
Key facts
- Insider
- Jeffrey S Farrow · Director
No transactions reported; holdings only.
Remarks: Power of Attorney attached as Exhibit 24.
More LSTA filings
- 8-K
Filed Nov 9, 2026
- ARS
Filed Oct 19, 2026
- DEF 14A
Filed Oct 19, 2026
- 8-K
Filed Oct 14, 2026
- PRE 14A
Filed Oct 7, 2026
- D
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.